Observational, Long-term, Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Studies
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Parkinsons Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 40 - Any |
| Updated: | 3/29/2019 |
| Start Date: | August 24, 2018 |
| End Date: | August 2026 |
An Observational, Long-Term Extension Study for Participants of Prior VY-AADC01 or VY-AADC02 Clinical Studies
An extension study for participants who have completed VY-AADC01 or VY-AADC02 Studies
Inclusion Criteria:
1. Participant in Voyager-sponsored clinical study of VY-AADC01 or VY-AADC02 gene therapy
2. Ability to comprehend and signed the informed consent, or for participants who are not
capable of providing consent, have a healthcare proxy, or person with power of
attorney, who is able and willing to give consent on behalf of the participant
3. Capable of complying with the protocol
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
